CUE icon

Cue Biopharma

100 hedge funds and large institutions have $393M invested in Cue Biopharma in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

35% more funds holding

Funds holding: 74100 (+26)

7.19% more ownership

Funds ownership: 49.2%56.39% (+7.2%)

15% less call options, than puts

Call options by funds: $1.29M | Put options by funds: $1.53M

Holders
100
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.29M
Puts
$1.53M
Net Calls
Net Calls Change

Top Buyers

1 +$16.2M
2 +$16.1M
3 +$14.8M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.1M
5
Citadel Advisors
Citadel Advisors
Florida
+$6.22M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$57M
2
$47.3M
3
$45.8M
4
$32.8M
5
$25.2M
6
$21.3M
7
$16.2M
8
$16.2M
9
$9.25M
10
$8.61M
11
$8.2M
12
$8.1M
13
$7.84M
14
$7.61M
15
$6.69M
16
$5.72M
17
$5.43M
18
$4.72M
19
$4.04M
20
$3.55M
21
$3.38M
22
$3.37M
23
$2.73M
24
$2.48M
25
$2.17M